Created in 2015 (Sweden), IMDAPZIM own 585 sister brands and 17478 competing brands. IMDAPZIM is owned by ASTRAZENECA, listed on the stock exchange of London The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. The sector of IMDAPZIM is Drug Manufacturers.